These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 23273765)
1. Shared gene regulation during human somatic cell reprogramming. Wang X; Chen X; Zhang H; Qin W; Xue Y; Zeng F J Genet Genomics; 2012 Dec; 39(12):613-23. PubMed ID: 23273765 [TBL] [Abstract][Full Text] [Related]
2. Comparison of reprogramming ability of mouse ES and iPS cells measured by somatic cell fusion. Sumer H; Nicholls C; Liu J; Tat PA; Liu JP; Verma PJ Int J Dev Biol; 2010; 54(11-12):1723-8. PubMed ID: 21404192 [TBL] [Abstract][Full Text] [Related]
3. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells. Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564 [TBL] [Abstract][Full Text] [Related]
4. A protein roadmap to pluripotency and faithful reprogramming. Wang J; Orkin SH Cells Tissues Organs; 2008; 188(1-2):23-30. PubMed ID: 18196921 [TBL] [Abstract][Full Text] [Related]
6. Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells. Mosca E; Cocola C; Sabour D; Pelucchi P; Bertalot G; Palumbo O; Carella M; Götte M; Schöler HR; Reinbold R; Zucchi I; Milanesi L In Silico Biol; 2010; 10(5-6):207-21. PubMed ID: 22430355 [TBL] [Abstract][Full Text] [Related]
7. Distinct MicroRNA Expression Signatures of Porcine Induced Pluripotent Stem Cells under Mouse and Human ESC Culture Conditions. Zhang W; Zhong L; Wang J; Han J PLoS One; 2016; 11(7):e0158655. PubMed ID: 27384321 [TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling of somatic and pluripotent cells reveals novel pathways involved in reprogramming. Cai YN; Dai XH; Zhang QH; Hu R; Dai ZM Genet Mol Res; 2015 Oct; 14(4):12085-92. PubMed ID: 26505355 [TBL] [Abstract][Full Text] [Related]
9. Self-organizing map of gene regulatory networks for cell phenotypes during reprogramming. Zhang L; Zheng Y; Li D; Zhong Y Comput Biol Chem; 2011 Aug; 35(4):211-7. PubMed ID: 21864790 [TBL] [Abstract][Full Text] [Related]
10. Identification of microRNAs regulated by activin A in human embryonic stem cells. Tsai ZY; Singh S; Yu SL; Kao LP; Chen BZ; Ho BC; Yang PC; Li SS J Cell Biochem; 2010 Jan; 109(1):93-102. PubMed ID: 19885849 [TBL] [Abstract][Full Text] [Related]
11. Increased dosage of tumor suppressors limits the tumorigenicity of iPS cells without affecting their pluripotency. Menendez S; Camus S; Herreria A; Paramonov I; Morera LB; Collado M; Pekarik V; Maceda I; Edel M; Consiglio A; Sanchez A; Li H; Serrano M; Belmonte JC Aging Cell; 2012 Feb; 11(1):41-50. PubMed ID: 21981310 [TBL] [Abstract][Full Text] [Related]
12. From skin to the treatment of diseases--the possibilities of iPS cell research in dermatology. Galach M; Utikal J Exp Dermatol; 2011 Jun; 20(6):523-8. PubMed ID: 21585557 [TBL] [Abstract][Full Text] [Related]
13. Live fluorescent RNA-based detection of pluripotency gene expression in embryonic and induced pluripotent stem cells of different species. Lahm H; Doppler S; Dreßen M; Werner A; Adamczyk K; Schrambke D; Brade T; Laugwitz KL; Deutsch MA; Schiemann M; Lange R; Moretti A; Krane M Stem Cells; 2015 Feb; 33(2):392-402. PubMed ID: 25335772 [TBL] [Abstract][Full Text] [Related]
14. Induction of pluripotency in human cord blood unrestricted somatic stem cells. Zaehres H; Kögler G; Arauzo-Bravo MJ; Bleidissel M; Santourlidis S; Weinhold S; Greber B; Kim JB; Buchheiser A; Liedtke S; Eilken HM; Graffmann N; Zhao X; Meyer J; Reinhardt P; Burr B; Waclawczyk S; Ortmeier C; Uhrberg M; Schöler HR; Cantz T; Wernet P Exp Hematol; 2010 Sep; 38(9):809-18, 818.e1-2. PubMed ID: 20541586 [TBL] [Abstract][Full Text] [Related]
15. TaqMan® OpenArray® high-throughput transcriptional analysis of human embryonic and induced pluripotent stem cells. Patel SN; Wu Y; Bao Y; Mancebo R; Au-Young J; Grigorenko E Methods Mol Biol; 2013; 997():191-201. PubMed ID: 23546757 [TBL] [Abstract][Full Text] [Related]
16. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Huangfu D; Osafune K; Maehr R; Guo W; Eijkelenboom A; Chen S; Muhlestein W; Melton DA Nat Biotechnol; 2008 Nov; 26(11):1269-75. PubMed ID: 18849973 [TBL] [Abstract][Full Text] [Related]
17. Molecular mechanism involved in the maintenance of pluripotent stem cells. Wong RC; Donovan PJ; Pébay A J Stem Cells; 2011; 6(4):213-32. PubMed ID: 23550339 [TBL] [Abstract][Full Text] [Related]
18. Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells. Pick M; Stelzer Y; Bar-Nur O; Mayshar Y; Eden A; Benvenisty N Stem Cells; 2009 Nov; 27(11):2686-90. PubMed ID: 19711451 [TBL] [Abstract][Full Text] [Related]
19. Macrohistone variants preserve cell identity by preventing the gain of H3K4me2 during reprogramming to pluripotency. Barrero MJ; Sese B; Kuebler B; Bilic J; Boue S; Martí M; Izpisua Belmonte JC Cell Rep; 2013 Apr; 3(4):1005-11. PubMed ID: 23545500 [TBL] [Abstract][Full Text] [Related]
20. Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. Ghosh Z; Wilson KD; Wu Y; Hu S; Quertermous T; Wu JC PLoS One; 2010 Feb; 5(2):e8975. PubMed ID: 20126639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]